ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 125 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.49 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $445,000 | +209.0% | 23,572 | +92.3% | 0.00% | – |
| Q2 2019 | $144,000 | -1.4% | 12,261 | +14.4% | 0.00% | – |
| Q1 2019 | $146,000 | -58.0% | 10,718 | -48.7% | 0.00% | – |
| Q3 2018 | $348,000 | +124.5% | 20,904 | +71.8% | 0.00% | – |
| Q1 2018 | $155,000 | +22.0% | 12,170 | +9.8% | 0.00% | – |
| Q4 2017 | $127,000 | -53.5% | 11,080 | +32.9% | 0.00% | – |
| Q3 2016 | $273,000 | +32.5% | 8,336 | +1.1% | 0.00% | – |
| Q2 2016 | $206,000 | – | 8,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Novo Holdings A/S | 3,201,183 | $40,591,000 | 3.96% |
| Cormorant Asset Management, LP | 150,000 | $1,902,000 | 0.39% |
| PFM Health Sciences, LP | 1,034,030 | $13,112,000 | 0.30% |
| Partner Investment Management, L.P. | 23,660 | $300,000 | 0.11% |
| PointState Capital LP | 375,000 | $4,755,000 | 0.09% |
| Spark Investment Management LLC | 38,400 | $486,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 89,300 | $1,132,000 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 95,722 | $1,214,000 | 0.05% |
| CADIAN CAPITAL MANAGEMENT, LP | 120,000 | $1,522,000 | 0.04% |
| Nicholas Investment Partners, LP | 49,341 | $626,000 | 0.04% |